Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Identification of potential therapeutic targets for atherosclerosis by analysing the gene signature related to different immune cells and immune regulators in atheromatous plaques

Fig. 3

Gene set enrichment analysis (GSEA) comparing atheromatous plaques with healthy control samples of GSE100927. KEGG canonical pathways were used as the a priori information for the GSEA. A Primary immunodeficiency, B leukocyte transendothelial migration, C antigen processing and presentation, D natural killer cell-mediated cytotoxicity, E T cell receptor signalling pathway, and F B cell receptor signalling pathway were highly enriched in atheromatous plaques

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us